Forgotten Infection Friday: Ecthyma Gangrenosum — The Rapidly Deadly Black Lesion

Forgotten Infection Friday: Ecthyma Gangrenosum — The Rapidly Deadly Black Lesion

This episode explains ecthyma gangrenosum: a rapidly evolving, black necrotic skin lesion most classically caused by Pseudomonas aeruginosa invading blood vessels. It covers the pathophysiology, stages of progression, risk factors (immunocompromise, neutropenia, diabetes), and how it differs from ordinary diabetic foot ulcers. Key takeaways: urgent tissue biopsy and cultures for diagnosis, prompt broad-spectrum IV antibiotics and surgical debridement for source control, and early recognition to prevent sepsis, limb loss, and death.

LIMBWatch Series: Riley Csernica, VP of Product Development at DARCO International: From Napkin to Norm: GO Line ™ Unveiled & The DARCO Story Behind Modern Offloading

On this episode of Limb Watch, Riley Csernica, VP of Product Development at DARCO International, recounts the company’s origin and explains the GO Line ™ innovations — including AirCore™ and PowerPods® — that improve offloading durability, gait stability, and patient adherence in diabetic foot care. She highlights how thoughtful footwear design helps clinicians protect wounds while preserving mobility and work ability, reduces replacement costs, and expands access to effective, long-lasting offloading solutions. If you want to explore the full range of DARCO GO Line ™ solutions—including advanced offloading footwear designed for wound prevention, post-operative recovery, and diabetic foot care—visit the official DARCO International product page. The GO Line ™ features innovative designs like the POGO® Athletic Offloading Sneaker and other clinically engineered systems focused on pressure redistribution, patient mobility, and protection during healing - https://darcointernational.com/go-line/ [https://darcointernational.com/go-line/]

The Wound That Hated Debridement: Recognizing Pathergy and Great mimics of Diabetic Foot Infection

A patient with a presumed infected diabetic foot ulcer worsens after debridement and escalating antibiotics. This episode explores pathergy — an exaggerated inflammatory response to minor trauma that can mimic infection — and how misdiagnosis leads to harmful over-treatment. Learn how to recognize red flags (rapid enlargement after intervention, pain out of proportion, violaceous borders, negative cultures) and why management often requires restraint, anti-inflammatory therapy, and targeted immunomodulation rather than repeated surgical debridement.

Escaping Plato’s Cave: Amputation Illusion- how healthcare learned to accept preventable limb loss

In this episode of Diabetic Foot Files Dr. G uses Plato's allegory of the cave to reveal how long‑standing assumptions and systemic failures—not just biology—drive many diabetes‑related amputations. He highlights delayed referrals, missed vascular assessments, poor offloading, and fragmented care as the real drivers behind the shadow of inevitability. Featuring the work of limb‑salvage pioneers,  the episode stresses that diabetic foot ulcers are medical emergencies where early detection, timely revascularization, aggressive offloading, and multidisciplinary teams can prevent many amputations. It’s a call to shift from reactive care to coordinated prevention so every limb has a chance.

From seizures to Granulation Nation: The Unexpected Story of Phenytoin in Wound Healing

This episode traces how phenytoin — an anticonvulsant known for causing gingival overgrowth — was repurposed into a topical therapy for chronic wounds. It outlines the drug’s mechanisms in wounds: activating fibroblasts, increasing collagen synthesis, reducing MMP activity, modulating inflammation, and promoting granulation and angiogenesis in stalled diabetic foot ulcers. Listeners will hear clinical implications, common formulations, and important cautions: topical phenytoin can aid healing in selected chronic ulcers but does not replace debridement, offloading, vascular optimization, or infection control, and should be avoided in malignant wounds, untreated osteomyelitis, or critical ischemia. The episode also highlights the drug’s history and future delivery innovations.